November 1, 2020
Briefings on APCs

Valerie A. Rinkle, MPA, CHRI, writes about Medicare guidance on and updated payment policies for COVID-19 testing, vaccines, and telehealth services.

October 14, 2020
News & Insights

CMS extended the timeline for organizations to repay payments received under its Accelerated and Advance Payment program, according to a fact sheet released October 8.

October 28, 2020
HIM Briefings

The discovery of an overpayment raises serious questions about compliance requirements. Understand your organization’s reporting obligation and appropriate methods for determining overpayments.

September 30, 2020
News & Insights

Organizations that received Provider Relief Fund payments of more than $10,000 will be required to report information on how PRF payments were used as well as  expenses related to the novel coronavirus that were not reimbursed (COVID-19), according to new HHS guidance.

September 23, 2020
News & Insights

UnitedHealthcare’s (UHC) plan to require in-network, freestanding and outpatient laboratory claims to contain a unique code for most lab testing services is poorly timed and poses significant implementation hurdles, the American Hospital Association (AHA) said.

September 14, 2020
News & Insights

Q: Per the 2021 Inpatient Prospective Payment System (IPPS) final rule, what MS-DRG charge information will be required to include on our cost report?

September 1, 2020
Briefings on APCs

Several recent changes affect hospitals’ 340B programs. Follow these eight tips to review and optimize your hospital’s 340B program.

August 26, 2020
News & Insights

CMS extended the education and operations testing period for the Appropriate Use Criteria (AUC) program for advanced diagnostic imaging through 2021. The education and operations testing period, which started January 1, 2020, was slated to close at the end of the year.

August 24, 2020
News & Insights

Q: What should be covered in a hospital's bad debt reporting compliance policy and procedure?

August 4, 2020
News & Insights

Facing the unprecedented COVID-19 public health emergency, CMS released the 2021 OPPS proposed rule later than ever before, with the agency generally reinforcing its recent focus on site-neutral payment policies, lowering reimbursement for drugs purchased under the 340B program, and adding more services to the list of prior authorization. 

Pages